Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
David Croteau, Steven S Rossi, Brookie M Best, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluid
David Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 5, 2011
Neurocognitive impact of substance use in HIV infection
Desiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Journal of Affective Disorders
|
July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individuals
Jayraan Badiee, David J Moore, J Hampton Atkinson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 28, 2011
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons
David J Moore, Miguel Arce, Suzanne Moseley, et al.
Journal of Neuroinflammation
|
April 1, 2017
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
Sanjay R Mehta, Josué Pérez-Santiago, Todd Hulgan, et al.
Neuroimmune Pharmacology and Therapeutics
|
August 25, 2025
Early-career research education mentoring: a successful program in NeuroHIV and mental health (TRNAMH)
Heather Thomas, Asante R Kamkwalala, Avindra Nath, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2012
Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
David Croteau, Steven S Rossi, Brookie M Best, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 2012
Therapeutic amprenavir concentrations in cerebrospinal fluid
David Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 5, 2011
Neurocognitive impact of substance use in HIV infection
Desiree A Byrd, Robert P Fellows, Susan Morgello, et al.
Journal of Affective Disorders
|
July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individuals
Jayraan Badiee, David J Moore, J Hampton Atkinson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
September 28, 2011
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons
David J Moore, Miguel Arce, Suzanne Moseley, et al.
Journal of Neuroinflammation
|
April 1, 2017
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
Sanjay R Mehta, Josué Pérez-Santiago, Todd Hulgan, et al.
Neuroimmune Pharmacology and Therapeutics
|
August 25, 2025
Early-career research education mentoring: a successful program in NeuroHIV and mental health (TRNAMH)
Heather Thomas, Asante R Kamkwalala, Avindra Nath, et al.
Page
of 4